In a reversal, the FDA is reconsidering its decision to end the shortage status of tirzepatide, after a recent lawsuit and intense public pressure, The Washington Post reported Oct. 21.
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.
It was the insistent questioning of my four-year-old grandson that goaded me into it. “Why is your tummy so big” he asked ...
The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...
A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...
Ozempic, Mounjaro and similar medications for Type 2 diabetes and weight loss could also help people struggling with addiction, according to a new study. Researchers found that people addicted to ...
The reconsideration follows an Oct. 11 lawsuit that prompted U.S. District Judge Mark Pittman to temporarily halt legal proceedings to give the FDA time to reassess its ruling.
The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to ...
Clinical and other trials for GLP-1 therapies have found an association between these drugs and diabetic retinopathy ...